Stay updated on Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial

Sign up to get notified when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:38:32.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record. This change may reflect a modification or new information related to the safety, activity, or distribution of the investigational drug 177Lu-3BP-227 in patients with solid tumors expressing Neurotensin receptor type 1.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:51.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria related to health conditions and prior treatments. This change provides more comprehensive information for researchers looking to enroll suitable candidates for the clinical study.
    Difference
    42%
    Check dated 2024-05-22T20:53:38.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely indicates a shift in the type of intervention related to medical and healthcare publications and documentation on the webpage.
    Difference
    0.9%
    Check dated 2024-05-01T21:59:01.000Z thumbnail image

Stay in the know with updates to Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.